Clinico-pathological study of atypical pathogens in community-acquired pneumonia: a prospective study.
BACKGROUND
Atypical respiratory pathogens such as Mycoplasma pneumoniae, Legionella species, and Chlamydia pneumoniae are isolated with increasing frequency from community-acquired pneumonia (CAP). This study highlights the importance of organisms responsible for CAP.


METHODS
One hundred consecutive patients with clinically and radiographically diagnosed CAP were evaluated from October 2005 to October 2006. Sputum, bronchoalveolar lavage, and blood samples were collected for microbiological culture. Determination was performed for specific immunoglobulin M (IgM) for Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophila, Coxiella burnettii, adenovirus, and influenza virus.


RESULTS
The most common isolated bacteria was Streptococcus pneumoniae (22%) followed by Haemophilus influenzae (18%). Mycoplasma pneumoniae was isolated from 5% and Legionella pneumophila was isolated from 5% of patients. The most common positive serological reaction was for Chlamydia pneumoniae (30%) and Adenovirus (30%). In the study of accuracy of determination of specific IgM for Mycoplasma pneumoniae and Legionella pneumophila compared to culture, the sensitivity was 60% and 80% respectively, specificity was 93.7 %, and 98.9 % respectively, and accuracy was 92 % and 97 % respectively.


CONCLUSIONS
This study highlights the prominence of mixed bacterial/viral infections in lower respiratory tract infection diagnosis. Our data showed that at least 30% of our patients had concurrent infections. This observation raises two important questions: 1) whether sequential or concurrent viral and bacterial infections have a synergistic impact on the evolution of disease in children; and 2) should diagnostic batteries for any patient with CAP include methods for detecting both the typical and atypical bacterial or viral pathogens.
El Sayed Zaki
Maysaa
M
Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Egypt. may_s65@hotmail.com
Goda
Tarek
T
D000914:Antibodies, Viral / Q000097:blood; D001769:Blood / Q000382:microbiology; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology; D017714:Community-Acquired Infections / Q000382:microbiology / Q000473:pathology* / Q000503:physiopathology* / Q000821:virology; D015897:Comorbidity; D006801:Humans; D018410:Pneumonia, Bacterial / Q000382:microbiology / Q000473:pathology* / Q000503:physiopathology*; D011024:Pneumonia, Viral / Q000473:pathology* / Q000503:physiopathology* / Q000821:virology; D015995:Prevalence; D011446:Prospective Studies; D013183:Sputum / Q000382:microbiology
D000914:Antibodies, Viral